论文部分内容阅读
肺癌是一个全球性问题。50%的患者被确诊时已经进展为无法治愈的晚期疾病,尽管临床医生不断努力,但各种化学治疗(化疗)方案获得的疗效均很有限。非小细胞肺癌(non-small cell lung cancer,NSCLC)约占肺癌的80%。由于缺乏早期诊断或诊断时高转移率,仅有不到10%的患者可以采用手术治疗。其预后很差,只有10%~15%的患者在确诊后可存活5年。预后极差的原因是在肺癌早期缺乏
Lung cancer is a global problem. Fifty percent of patients have been diagnosed with advanced non-curable advanced disease and despite the constant efforts of clinicians, the efficacy of various chemotherapy (chemotherapy) regimens is limited. Non-small cell lung cancer (NSCLC) accounts for about 80% of lung cancer. Due to the lack of early diagnosis or high metastatic rate at diagnosis, less than 10% of patients can be treated surgically. Its prognosis is poor, only 10% to 15% of patients can survive 5 years after diagnosis. The reason for the poor prognosis is the lack of early lung cancer